Skip Navigation

Link to  the National Institutes of Health NIDA NEWS NIDA News RSS Feed
The Science of Drug Abuse and Addiction from the National Institute on Drug Abuse Keep Your Body Healthy
Go to the Home pageGo to the About Nida pageGo to the News pageGo to the Meetings & Events pageGo to the Funding pageGo to the Publications page
PhysiciansResearchersParents/TeachersStudents/Young AdultsEn Español

NIDA Home > About NIDA > Organization   

National Advisory Council on Drug Abuse



Department of Health and Human Services
National Institutes of Health
National Institute on Drug Abuse

103rd Meeting
National Advisory Council on Drug Abuse
Neuroscience Center - Conference Room C
6001 Executive Boulevard, Bethesda, MD.


September 15, 2009

Closed Session

This meeting is closed to the public in accordance with the provisions set forth in section 552b{c} and 552b{c}(6), Title 5, U.S. Code and section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2).

2:00 p.m. Call to Order
Nora D. Volkow, M.D., Director, NIDA

Review of and Policy Procedures
Teresa Levitin, Ph.D., Executive Secretary,
National Advisory Council on Drug Abuse


Council Review of Grant Applications
Nora Volkow, M.D., Director, and
Timothy P. Condon, Ph.D., Deputy Director, NIDA


Division of Basic Neuroscience and Behavioral Research (DBNBR)
David Shurtleff, Ph.D., Director

Division of Clinical Neuroscience and Behavioral Research (DCNBR)
Joseph Frascella, Ph.D., Director

Division of Epidemiology, Services and Prevention Research (DESPR)
Wilson Compton, M.D., M.P.E., Director

Division of Pharmacotherapies and Medical Consequences of Drug Abuse (DPMCDA)
David McCann, Ph.D., Acting Director
Office of Science Policy and Communications (OSPC)
Lucinda Miner, Ph.D., Deputy Directo

AIDS Research Program (Avant Garde Applications)
Jacques Normand, Ph.D., Direct

American Recovery and Reinvestment Act (ARRA)
Christine Colvis, Ph.D., Director of Program Integration

5:00 p.m. Adjourn


September 16, 2009

Open Session

8:30 - 8:45 a.m. Opening and Welcome
Nora Volkow, M.D., Director, NIDA
8:45 - 9:45 a.m. Director's Report
Nora Volkow, M.D.
Director, NIDA
9:45 - 10:15 a.m. Council Discussion
10:15 - 10:30 a.m. Break
10:30 - 11:00 a.m. Update on the AIDS Research Program
Jacques Normand, Ph.D.
Director, AIDS Research Program
11:00 - 11:30 a.m. Community Influences on Drug Abuse: Challenges, Successes and Opportunities for Research
Wilson Compton, M.D., M.P.E.
Director, Division of Epidemiology, Services & Prevention Branch, NIDA
11:30 - 11:45 a.m. Update on the American Recovery and Reinvestment Act
Christine Colvis, Ph.D.
Director of Program Integration, OD, NIDA
11:45 - Noon Public Comments
Noon Adjourn

About NIDA Contents




NIDA Home | Site Map | Search | FAQs | Accessibility | Privacy | FOIA (NIH) | Employment |



National Institutes of Health logo_Department of Health and Human Services Logo The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH) , a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. Last updated on Tuesday, August 25, 2009. The U.S. government's official web portal